TELA · ISSUER CIK 1561921
TELA Bio, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 TELA Bio, Inc. insiders reported $186K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Capper Joseph H (Director), with $167K.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$186KInsider buying
$0.00Insider selling
+$186KNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202617:08 | Oct 15, 2026 | TELA | Director | A · Grant | $1.01 | +19,801 | 199,628 | +11% | $20K | ||
| Oct 19, 202617:07 | Oct 15, 2026 | TELA | Director | A · Grant | $1.01 | +16,089 | 60,619 | +36% | $16K | ||
| Sep 18, 202616:30 | Sep 17, 2026from Sep 16, 2026 | TELA | Director | P · Buy | $1.18 | +75,000 | 179,827 | +72% | +$89K | +8.6% | -22.3% |
| Sep 16, 202618:46 | Sep 15, 2026from Sep 14, 2026 | TELA | Director | P · Buy | $1.05 | +75,000 | 104,827 | +251% | +$78K | +7.8% | -12.0% |
| Aug 19, 202616:10 | Aug 17, 2026 | TELA | Chief Executive Officer, Director | P · Buy | $0.66 | +12,500 | 532,500 | +2% | +$8K | -31.4% | +38.4% |
| Aug 17, 202616:32 | Aug 14, 2026 | TELA | Chief Executive Officer, Director | P · Buy | $0.70 | +15,000 | 520,000 | +3% | +$10K | -28.1% | +31.8% |
| Aug 5, 202616:09 | Aug 3, 2026 | TELA | Chief Executive Officer, Director | A · Grant | — | +500,000 | 505,000 | +10000% | — |